These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 23465600)

  • 1. Evaluation of reactive Epstein-Barr Virus (EBV) in Iranian patient with different subtypes of multiple sclerosis (MS).
    Ramroodi N; Niazi AA; Sanadgol N; Ganjali Z; Sarabandi V
    Braz J Infect Dis; 2013; 17(2):156-63. PubMed ID: 23465600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
    Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G
    Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review and meta-analysis of the sero-epidemiological association between Epstein Barr virus and multiple sclerosis.
    Almohmeed YH; Avenell A; Aucott L; Vickers MA
    PLoS One; 2013; 8(4):e61110. PubMed ID: 23585874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Epstein-Barr virus-specific antibodies in Cypriot multiple sclerosis patients.
    Deeba E; Koptides D; Gaglia E; Constantinou A; Lambrianides A; Pantzaris M; Krashias G; Christodoulou C
    Mol Immunol; 2019 Jan; 105():270-275. PubMed ID: 30562647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus and disease activity in multiple sclerosis.
    Buljevac D; van Doornum GJ; Flach HZ; Groen J; Osterhaus AD; Hop W; van Doorn PA; van der Meché FG; Hintzen RQ
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1377-81. PubMed ID: 16170080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time Epstein-Barr virus PCR for the diagnosis of primary EBV infections and EBV reactivation.
    Luderer R; Kok M; Niesters HG; Schuurman R; de Weerdt O; Thijsen SF
    Mol Diagn; 2005; 9(4):195-200. PubMed ID: 16392898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus reactivation and multiple sclerosis.
    Torkildsen Ø; Nyland H; Myrmel H; Myhr KM
    Eur J Neurol; 2008 Jan; 15(1):106-8. PubMed ID: 18042233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma viral load of Epstein-Barr virus and risk of multiple sclerosis.
    Wagner HJ; Munger KL; Ascherio A
    Eur J Neurol; 2004 Dec; 11(12):833-4. PubMed ID: 15667414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The beneficial effects of vitamin D3 on reducing antibody titers against Epstein-Barr virus in multiple sclerosis patients.
    Najafipoor A; Roghanian R; Zarkesh-Esfahani SH; Bouzari M; Etemadifar M
    Cell Immunol; 2015 Mar; 294(1):9-12. PubMed ID: 25666504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.
    Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
    JAMA; 2005 May; 293(20):2496-500. PubMed ID: 15914750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EBV & HHV6 reactivation is infrequent and not associated with MS clinical course.
    Simpson S; Taylor B; Burrows J; Burrows S; Dwyer DE; Taylor J; Ponsonby AL; Blizzard L; Dwyer T; Pittas F; van der Mei I
    Acta Neurol Scand; 2014 Nov; 130(5):328-37. PubMed ID: 24893674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of viral antibodies in Iranian multiple sclerosis patients.
    Khaki M; Ghazavi A; Ghasami K; Rafiei M; Payani MA; Ghaznavi-Rad E; Mosayebi G
    Neurosciences (Riyadh); 2011 Jul; 16(3):224-8. PubMed ID: 21677611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.
    Ascherio A; Munger KL; Lennette ET; Spiegelman D; Hernán MA; Olek MJ; Hankinson SE; Hunter DJ
    JAMA; 2001 Dec; 286(24):3083-8. PubMed ID: 11754673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral immune response in patients with multiple sclerosis, healthy siblings and twins.
    Ristori G; Mechelli R; Anderson J; Mengoni F; Sauzullo I; Annibali V; Cannoni S; Aloisi F; James JA; Salvetti M
    Mult Scler; 2010 Dec; 16(12):1527-8. PubMed ID: 20798134
    [No Abstract]   [Full Text] [Related]  

  • 16. Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: A peptide microarray-based case-control study.
    Schlemm L; Giess RM; Rasche L; Pfuhl C; Wakonig K; Behrens JR; Scheibenbogen C; Bellmann-Strobl J; Paul F; Reimer U; Ruprecht K
    J Neuroimmunol; 2016 Aug; 297():56-62. PubMed ID: 27397076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis and Epstein-Barr virus.
    Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
    JAMA; 2003 Mar; 289(12):1533-6. PubMed ID: 12672770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples.
    Salzer J; Nyström M; Hallmans G; Stenlund H; Wadell G; Sundström P
    Mult Scler; 2013 Oct; 19(12):1587-91. PubMed ID: 23549431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered prevalence and reactivity of anti-Epstein-Barr virus antibodies in patients with multiple sclerosis.
    Wagner HJ; Hennig H; Jabs WJ; Siekhaus A; Wessel K; Wandinger KP
    Viral Immunol; 2000; 13(4):497-502. PubMed ID: 11192296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus in multiple sclerosis.
    Abdelrahman HS; Selim HS; Hashish MH; Sultan LI
    J Egypt Public Health Assoc; 2014 Aug; 89(2):90-5. PubMed ID: 25162741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.